IoFlow, a company specializing in wearable insulin pumps, has hit the upper price limit.
As of 2:50 PM on the 18th, IoFlow is trading on the KOSDAQ market at 13,650 KRW, up 3,150 KRW (30%) from the previous day.
IoFlow's main products consist of a smart wearable system targeting patients who require insulin infusion within the diabetes market, one of the representative chronic wasting diseases.
IoFlow experienced a decline for eight consecutive trading days from the 4th to the 14th, closed flat on the 17th, and then rose to the upper price limit the following day.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
